| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/15/2004 | WO2004014835A3 Resolvins: biotemplates for therapeutic interventions |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2004002398A3 Spherical pellet containing a water-soluble active ingredient |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003088956A8 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003013433A3 Sequestered antagonist formulations |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | WO2002000227A8 Use of lanthanum compounds for the treatment of bone diseases |
| 04/15/2004 | US20040073280 Method of controlling body temperature while reducing shivering |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |
| 04/15/2004 | US20040072884 Antipyretics, analgesics, antiinflammatory agents; side effect reduction |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072845 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl] piperazine |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
| 04/15/2004 | US20040072827 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072798 Compositions comprising cyclodextrins and no-releasing drugs |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072725 Orinithine and/or one or more branched amino acids(leucine, isoleucine and valine) in a concentration effective for treating or preventing inflammatory disease such as arthritis |
| 04/15/2004 | US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072237 Diagnosing inflammatory syndromes in mammals via monitoring altered gene expression patterns of endothelial growth factor, interleukins and/or tumor necrosis factor receptors |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040071792 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity |
| 04/15/2004 | US20040071770 Free radical scavenging liposome containing mixture of beta-carotene, vitamin E, vitamin C, glutathione, niacin, and/or trace metal; quenching |
| 04/15/2004 | US20040071764 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 04/15/2004 | US20040071735 Bone and muscular disorder treatment |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071701 Nerve growth factor antagonist for treating pain caused by physiological disorder, no side effects |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2500844A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 04/15/2004 | CA2499736A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/14/2004 | EP1408334A1 Procalcitonin 3-116 |
| 04/14/2004 | EP1408112A1 MONOCLONAL ANTIBODY BINDING TO MT4−MMP CATALYTIC DOMAIN |
| 04/14/2004 | EP1408033A1 Dibenzocycloheptene compound |
| 04/14/2004 | EP1408030A1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 04/14/2004 | EP1407795A2 Nasal delivery devices |
| 04/14/2004 | EP1407777A1 Preventives or remedies for arthritis |
| 04/14/2004 | EP1407771A1 Sophoridine and use thereof as an analgesic |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407767A1 Pparg agonistic medicinal compositions |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1406946A1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 04/14/2004 | EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406895A1 Lactone formulations and method of use |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406878A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 04/14/2004 | EP1406876A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406867A2 Thiolalkyl benzoic acid derivatives |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406865A2 Succinic acid derivatives |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406667A2 METHODS FOR INCREASING i IN VIVO /i EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406660A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406652A2 Novel drug targets for arthritis |
| 04/14/2004 | EP1406635A2 A controlled release anti-inflammatory formulation and a process for the preparation thereof |